M
Mary Lee Vance
Researcher at University of Virginia
Publications - 159
Citations - 14198
Mary Lee Vance is an academic researcher from University of Virginia. The author has contributed to research in topics: Acromegaly & Growth hormone secretion. The author has an hindex of 61, co-authored 156 publications receiving 13379 citations. Previous affiliations of Mary Lee Vance include University of Virginia Health System & National Science Foundation.
Papers
More filters
Journal ArticleDOI
Estrogen receptors in prolactinomas: a clinico-pathological study.
George J. Kaptain,Nathan E. Simmons,Tord D. Alden,Maria Beatriz Lopes,Mary Lee Vance,Edward R. Laws +5 more
TL;DR: In this paper, the use of antiestrogen therapy in pituitary adenomas has not been explored, however, the authors attempted to identify a population who may benefit from antiestrogens therapy.
Journal ArticleDOI
Role of medical therapy in the management of acromegaly
Mary Lee Vance,Edward R. Laws +1 more
TL;DR: Pegvisomant is highly effective in achieving normal IGF-I concentrations and in reducing signs and symptoms of acromegaly, even in patients resistant to previous treatments, and may have a beneficial effect on carbohydrate metabolism and cardiovascular risk.
Journal ArticleDOI
Cushing's disease: radiation therapy.
TL;DR: Until radiation treatment becomes effective, medical therapy to lower cortisol production is indicated, and medical therapy should be discontinued every 6 months to assess response to radiation treatment; a normal 24 h urine free cortisol being the optimal outcome.
Journal ArticleDOI
Radiation dose to neuroanatomical structures of pituitary adenomas and the effect of Gamma Knife radiosurgery on pituitary function.
I. Jonathan Pomeraniec,Davis G. Taylor,Or Cohen-Inbar,Zhiyuan Xu,Mary Lee Vance,Jason P. Sheehan +5 more
TL;DR: Point dosimetry to specific neuroanatomical structures revealed that a ratio of stalk-to-gland radiation dose of 0.8 or more significantly increased the risk of endocrinopathy following GKRS, and patients who are treated with a high dose to the pituitary stalk relative to the normal gland are at higher risk of post-GKRS endocrineopathy.
Journal ArticleDOI
Growth and the Child with Diabetes Mellitus
TL;DR: Findings suggest that even today's more modest levels of hyperglycemia and/or underinsulinization could be associated with potentially serious consequences for children in the future, including the development and progression of diabetic retinopathy.